• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病关节炎治疗新理念:可否靶向治疗?

Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?

机构信息

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LD, UK.

Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK.

出版信息

Curr Rheumatol Rep. 2018 Sep 18;20(11):71. doi: 10.1007/s11926-018-0781-x.

DOI:10.1007/s11926-018-0781-x
PMID:30229387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6153572/
Abstract

PURPOSE OF REVIEW

Psoriatic arthritis (PsA) is a chronic inflammatory spondyloarthritis that can cause progressive joint damage and irreversible disability. Advances in modern therapies, now mean a target of remission is an achievable goal in PsA. There is strong and consistent evidence that a treat-to-target (T2T) approach to PsA management results in better patient outcomes; however, the practicalities of incorporating this strategy into routine clinical practice remain a challenge. The heterogeneous nature of this condition and the need for validated outcome measures have to-date hampered consensus on a definition of remission. This review aims to summarise the current T2T research landscape in PsA and highlight potential roles for biomarkers and imaging advances in revolutionising the T2T concept.

RECENT FINDINGS

There is a growing body of evidence to support the implementation of a T2T strategy, using a pre-defined target in PsA management, with significant benefits in disease outcome, physical function and quality of life. Whilst remission is the ultimately goal for PsA patients and their clinicians, further comparative studies of different treatment targets are needed to establish a widely acceptable definition of remission.

摘要

目的综述

银屑病关节炎(PsA)是一种慢性炎症性脊柱关节炎,可导致进行性关节损伤和不可逆转的残疾。现代治疗方法的进步意味着达到缓解是 PsA 的一个可实现的目标。有强有力且一致的证据表明,针对银屑病关节炎管理的达标治疗(T2T)方法可带来更好的患者结局;然而,将这一策略纳入常规临床实践的实际情况仍然具有挑战性。这种疾病的异质性以及对验证后结果测量指标的需求,迄今为止一直阻碍着对缓解定义达成共识。本篇综述旨在总结目前银屑病关节炎中的 T2T 研究现状,并强调生物标志物和影像学进展在彻底改变 T2T 概念方面的潜在作用。

最新发现

越来越多的证据支持在银屑病关节炎管理中实施 T2T 策略,使用预先定义的目标,在疾病结局、身体功能和生活质量方面具有显著益处。虽然缓解是银屑病关节炎患者及其临床医生的最终目标,但需要进一步比较不同治疗目标的研究,以确定广泛接受的缓解定义。

相似文献

1
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?银屑病关节炎治疗新理念:可否靶向治疗?
Curr Rheumatol Rep. 2018 Sep 18;20(11):71. doi: 10.1007/s11926-018-0781-x.
2
Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design.针对银屑病关节炎的目标治疗:评估真实世界结局并优化银屑病关节炎成人的治疗策略-MONITOR-PsA 研究方案,一种队列内试验设计研究。
Trials. 2021 Mar 4;22(1):185. doi: 10.1186/s13063-021-05142-7.
3
Considerations for the definition of remission criteria in psoriatic arthritis.考虑到银屑病关节炎缓解标准的定义。
Semin Arthritis Rheum. 2018 Jun;47(6):786-796. doi: 10.1016/j.semarthrit.2017.10.021. Epub 2017 Oct 31.
4
Treat to target in psoriatic arthritis-evidence, target, research agenda.银屑病关节炎的达标治疗——证据、目标与研究议程
Curr Rheumatol Rep. 2015 Jun;17(6):517. doi: 10.1007/s11926-015-0517-0.
5
Treating to target in psoriatic arthritis.银屑病关节炎的达标治疗
Curr Opin Rheumatol. 2015 Mar;27(2):107-10. doi: 10.1097/BOR.0000000000000140.
6
Treat-to-target in PsA: methods and necessity.靶向治疗在银屑病关节炎中的应用:方法与必要性。
RMD Open. 2020 Feb;6(1). doi: 10.1136/rmdopen-2019-001083.
7
Psoriatic arthritis: is it time to treat-to-target or target to treat?银屑病关节炎:是否到了达标治疗或针对治疗的时机?
Clin Rheumatol. 2017 Dec;36(12):2633-2635. doi: 10.1007/s10067-017-3885-1. Epub 2017 Oct 24.
8
Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.银屑病关节炎十年随访数据:基于挪威南部普通门诊患者标准化监测的结果。
Arthritis Res Ther. 2018 Aug 2;20(1):160. doi: 10.1186/s13075-018-1659-z.
9
Clinical remission in rheumatoid arthritis and psoriatic arthritis.类风湿关节炎和银屑病关节炎的临床缓解。
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):900-910. Epub 2018 Mar 16.
10
What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?银屑病关节炎“达标治疗”的主要目标应该是什么?
J Rheumatol. 2019 Jan;46(1):38-42. doi: 10.3899/jrheum.180267. Epub 2018 Sep 15.

引用本文的文献

1
Serum Interleukin (IL)-6, Lipid Profile, and Association With Disease Severity in Patients With Psoriasis: A Cross-Sectional Study.银屑病患者血清白细胞介素(IL)-6、血脂水平及其与疾病严重程度的关联:一项横断面研究
Cureus. 2024 Sep 17;16(9):e69599. doi: 10.7759/cureus.69599. eCollection 2024 Sep.
2
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists.银屑病关节炎的管理:风湿病专家的共识意见
Front Med (Lausanne). 2023 Nov 30;10:1327931. doi: 10.3389/fmed.2023.1327931. eCollection 2023.
3
A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA).一项关于银屑病关节炎治疗惰性的前瞻性调查(OPTI'PsA)。
Rheumatology (Oxford). 2024 Feb 1;63(2):516-524. doi: 10.1093/rheumatology/kead262.
4
A Joint Consensus of Rheumatologists and Dermatologists on Early Detection and Effective Management of Psoriatic Arthritis: India's Perspective.印度视角:风湿病学家和皮肤科医生关于银屑病关节炎早期检测与有效管理的联合共识
Indian J Dermatol. 2022 Jul-Aug;67(4):479. doi: 10.4103/ijd.ijd_939_20.
5
Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence.银屑病关节炎患者中与治疗反应欠佳相关的残余疾病:真实世界证据的系统评价
Rheumatol Ther. 2022 Jun;9(3):803-821. doi: 10.1007/s40744-022-00443-y. Epub 2022 Apr 12.
6
Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients.治疗达标理念在银屑病关节炎患者评估中的应用
J Clin Med. 2021 Nov 30;10(23):5659. doi: 10.3390/jcm10235659.
7
Consensus-based recommendations on the diagnosis, referral and clinical management of patients with psoriatic arthritis.基于共识的银屑病关节炎患者诊断、转诊和临床管理建议。
Rheumatol Int. 2022 Mar;42(3):391-401. doi: 10.1007/s00296-021-05029-5. Epub 2021 Oct 30.
8
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years.过去 13 年中风湿性疾病患者使用生物制剂的模式变化。
Sci Rep. 2021 Jul 23;11(1):15051. doi: 10.1038/s41598-021-94504-x.
9
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.白介素 12/23 抑制(乌司奴单抗)与肿瘤坏死因子抑制在银屑病关节炎中的疗效比较:观察性 PsABio 研究结果。
Ann Rheum Dis. 2021 Nov;80(11):1419-1428. doi: 10.1136/annrheumdis-2021-220263. Epub 2021 Jun 23.
10
Treating to Target in Clinical Practice: The Results of a Questionnaire Completed by Greek Rheumatologists.临床实践中的达标治疗:希腊风湿病学家填写的一份调查问卷结果
Mediterr J Rheumatol. 2020 May 25;31(Suppl 1):145-151. doi: 10.31138/mjr.31.1.145. eCollection 2020 Jun.

本文引用的文献

1
Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.银屑病关节炎十年随访数据:基于挪威南部普通门诊患者标准化监测的结果。
Arthritis Res Ther. 2018 Aug 2;20(1):160. doi: 10.1186/s13075-018-1659-z.
2
Considerations for the definition of remission criteria in psoriatic arthritis.考虑到银屑病关节炎缓解标准的定义。
Semin Arthritis Rheum. 2018 Jun;47(6):786-796. doi: 10.1016/j.semarthrit.2017.10.021. Epub 2017 Oct 31.
3
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.银屑病和银屑病关节炎研究与评估小组/风湿病学结局指标共识推荐意见及银屑病关节炎中使用复合指标和治疗目标的研究计划。
Arthritis Rheumatol. 2018 Mar;70(3):345-355. doi: 10.1002/art.40391. Epub 2018 Feb 6.
4
Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.银屑病关节炎的理想治疗靶点?真实队列中缓解与低疾病活动度状态的比较。
Ann Rheum Dis. 2018 Feb;77(2):251-257. doi: 10.1136/annrheumdis-2017-211998. Epub 2017 Oct 28.
5
Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.血清骨转换生物标志物与银屑病患者外周和中轴关节炎的发生相关:一项前瞻性横断面比较研究。
Arthritis Res Ther. 2017 Sep 21;19(1):210. doi: 10.1186/s13075-017-1417-7.
6
The association between sonographic enthesitis and radiographic damage in psoriatic arthritis.银屑病关节炎中超声检查的附着点炎与放射学损伤之间的关联。
Arthritis Res Ther. 2017 Aug 15;19(1):189. doi: 10.1186/s13075-017-1399-5.
7
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.治疗中轴型脊柱关节炎和外周型脊柱关节炎,尤其是银屑病关节炎,以达治疗目标:国际特别工作组2017年推荐更新版
Ann Rheum Dis. 2018 Jan;77(1):3-17. doi: 10.1136/annrheumdis-2017-211734. Epub 2017 Jul 6.
8
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.治疗银屑病和银屑病关节炎:关于将治疗达标理念应用于加拿大日常医疗实践的立场文件。
J Rheumatol. 2017 Apr;44(4):519-534. doi: 10.3899/jrheum.161473.
9
Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.比较针对接受 csDMARD 和 bDMARD 治疗的银屑病关节炎的综合指标:一项纵向队列的横断面分析。
J Rheumatol. 2017 Aug;44(8):1159-1164. doi: 10.3899/jrheum.170112. Epub 2017 Jun 1.
10
Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial.早期银屑病关节炎炎症的严格控制的成本效益:一项多中心随机对照试验的经济学分析。
Arthritis Care Res (Hoboken). 2018 Mar;70(3):462-468. doi: 10.1002/acr.23293. Epub 2018 Jan 30.